Data on SOPHIA Trial in HER+ Metastatic Breast Cancer

Data on SOPHIA Trial in HER+ Metastatic Breast Cancer
Don Photo

Don
3 ปี 119 Views
ประเภท:
ลักษณะ:
Neelima Denduluri MD, Associate Professor, US Oncology Research, Virginia Cancer Specialists explains the results from the SOPHIA trial, a phase III study of chemotherapy plus margetuximab or trastuzumab in HER+ metastatic breast cancer.